FBLAX
Price
$13.49
Change
-$0.05 (-0.37%)
Updated
Jun 10 closing price
Net Assets
3.45B
HBLRX
Price
$14.97
Change
-$0.06 (-0.40%)
Updated
Jun 10 closing price
Net Assets
11.21B
Interact to see
Advertisement

FBLAX vs HBLRX

Header iconFBLAX vs HBLRX Comparison
Open Charts FBLAX vs HBLRXBanner chart's image
FBLAX vs HBLRX Comparison Chart in %
View a ticker or compare two or three
VS
FBLAX vs. HBLRX commentary
Jun 11, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBLAX is a Buy and HBLRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
HBLRX has more cash in the bank: 11.2B vs. FBLAX (3.45B). FBLAX pays higher dividends than HBLRX: FBLAX (4.27) vs HBLRX (2.80). FBLAX was incepted earlier than HBLRX: FBLAX (20 years) vs HBLRX (16 years). HBLRX (1.27) is less costly to investors than FBLAX (0.91). HBLRX is a more actively managed with annual turnover of: 90.00 vs. FBLAX (42.27). HBLRX has a lower initial minimum investment than FBLAX: HBLRX (0) vs FBLAX (1000). FBLAX annual gain was more profitable for investors over the last year : 13.70 vs. HBLRX (5.62). FBLAX return over 5 years is better than : 19.69 vs. HBLRX (3.46).
FBLAXHBLRXFBLAX / HBLRX
Total Expense Ratio0.911.2772%
Annual Report Gross Expense Ratio0.911.2772%
Fund Existence20 years16 years-
Gain YTD6.2393.475180%
Front Load6%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.45B11.2B31%
Annual Yield % from dividends4.272.80153%
Returns for 1 year13.705.62244%
Returns for 3 years27.7018.92146%
Returns for 5 years19.693.46568%
Returns for 10 years59.1736.78161%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KOD31.410.35
+1.13%
Kodiak Sciences
BEAGU10.920.01
+0.09%
Bold Eagle Acquisition Corp
EHC103.35-0.84
-0.81%
Encompass Health Corp
UPXI0.86-0.03
-3.48%
Upexi Inc
OCGN1.20-0.05
-3.63%
Ocugen